| II-73 Carlos Perez-Ruixo Exposure-response relationships of the efficacy and safety of apalutamide (APA) in men with non-metastatic castration-resistant prostate cancer (nmCRPC) Wednesday 15:10-16:40 |
| II-73 Carlos Perez-Ruixo Exposure-response relationships of the efficacy and safety of apalutamide (APA) in men with non-metastatic castration-resistant prostate cancer (nmCRPC) Wednesday 15:10-16:40 |